• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Germany

image of CSLs new RD facility
Biotech

CSL Behring unveils its largest R&D site, slated to open in 2022

After three years of construction, CSL Behring has unveiled its new R&D site in Marburg, Germany, slated to be the company's largest.
Max Bayer Sep 14, 2022 10:45am
deal

ResMed continues German expansion with Mementor buy

Aug 2, 2022 1:00pm
COVID-19 danger coronavirus pandemic quarantine

InflaRx to take failed COVID treatment to FDA anyway

Jul 26, 2022 11:20am
acquisition magnet

ResMed drops $1B on German software developer

Jun 14, 2022 10:50am
mouse

A common cancer immunotherapy target might also work in obesity

Mar 9, 2022 2:00pm
Heidelberg Germany

Huadong inks $930M licensing deal for four Heidelberg assets

Feb 28, 2022 11:34am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy